Suppr超能文献

脊髓内巴氯芬泵的导管翻修:危险因素和术后结果。

Spinal catheter revision in pediatric intrathecal baclofen pumps: risk factors and postoperative outcomes.

机构信息

1Department of Neurosurgery and.

2Baclofen Pump Program, Boston Children's Hospital, Boston, Massachusetts.

出版信息

Neurosurg Focus. 2024 Jun;56(6):E11. doi: 10.3171/2024.3.FOCUS2467.

Abstract

OBJECTIVE

Intrathecal baclofen (ITB) pumps are commonly used in pediatric patients with cerebral palsy (CP) and medically refractory spasticity. However, catheter malfunction and associated risk factors are not well understood. The aim of this study was to examine potential risk factors for spinal catheter malfunction and characterize postoperative follow-up to understand the clinical consequences.

METHODS

Patients who received ITB pump replacement or revision at Boston Children's Hospital between 2010 and 2023 were retrospectively reviewed. The spinal catheter revision cohort (SCRC) included patients whose spinal catheter was occluded requiring lumbar catheter revision. The second cohort included abdominal pump replacements only (APRC). Between-group comparisons and multivariable regression identified factors associated with catheter revision and postoperative outcomes.

RESULTS

Forty-one (33.6%) patients underwent spinal catheter revision and were compared with 81 patients (66.4%) who underwent abdominal pump replacement only. Younger age at surgery and an elevated preoperative lower-extremity modified Ashworth scale grade were associated with spinal catheter revision (p < 0.05). Catheter model type, tip location, and history of spinal fusion were not associated with obstruction. Postoperatively, SCRC patients experienced a higher rate of infection (17.1%) relative to APRC patients (0%) within 30 days from their ITB pump replacement procedure (p < 0.05) and greater likelihood of subsequent ITB system removal compared with the APRC (24.4% vs 7.4%, p < 0.05). Although not differing preoperatively, SCRC patients had lower postoperative ITB doses when compared with the APRC group (median dose 143 vs 350 µg/day, p < 0.05) at hospital discharge and remained statistically different at the 6-month and 1-year follow-ups (p < 0.05). There were no postoperative differences in baclofen overdose, withdrawal, or median number of hospital readmissions within 30 days. Overall, 31.7% of spinal catheter revisions were unanticipated by the clinical team at time of surgery.

CONCLUSIONS

Younger age at surgery and increased preoperative lower-extremity tone may be risk factors for catheter obstruction, resulting in a higher rate of postoperative infection and subsequent ITB pump removal compared with pump replacement alone. Spinal catheter occlusion can complicate revision or replacement procedures, especially when unanticipated. Routine clinical assessment may be inadequate for diagnosing insidious catheter malfunction. Catheter occlusion deserves further study, and routine assessment of catheter patency may be warranted to prevent suboptimal tone therapy.

摘要

目的

鞘内注射巴氯芬(ITB)泵常用于脑瘫(CP)和药物难治性痉挛的儿科患者。然而,导管故障及其相关危险因素尚不清楚。本研究的目的是研究潜在的脊髓导管故障的危险因素,并描述术后随访以了解临床后果。

方法

回顾性分析 2010 年至 2023 年期间在波士顿儿童医院接受 ITB 泵更换或修订的患者。脊髓导管修订队列(SCRC)包括脊髓导管阻塞需要腰椎导管修订的患者。第二队列包括仅腹部泵更换(APRC)。组间比较和多变量回归确定了与导管修订和术后结果相关的因素。

结果

41 名(33.6%)患者接受了脊髓导管修订,与 81 名(66.4%)仅接受腹部泵更换的患者进行了比较。手术时年龄较小和术前下肢改良 Ashworth 分级较高与脊髓导管修订相关(p < 0.05)。导管模型类型、尖端位置和脊柱融合史与阻塞无关。术后,SCRC 患者在 ITB 泵更换手术后 30 天内发生感染的比例(17.1%)高于 APRC 患者(0%)(p < 0.05),与 APRC 相比,更有可能随后移除 ITB 系统(24.4%比 7.4%,p < 0.05)。尽管术前没有差异,但与 APRC 组相比,SCRC 患者出院时的术后 ITB 剂量较低(中位数剂量 143 比 350 µg/天,p < 0.05),在 6 个月和 1 年随访时仍存在统计学差异(p < 0.05)。术后 30 天内,巴氯芬过量、撤药或中位数住院次数无差异。总体而言,31.7%的脊髓导管修订手术是临床团队在手术时未预料到的。

结论

手术时年龄较小和术前下肢肌张力增加可能是导管阻塞的危险因素,与单独更换泵相比,术后感染和随后 ITB 泵移除的发生率更高。脊髓导管阻塞会使修订或更换手术复杂化,尤其是当未预料到时。常规临床评估可能不足以诊断隐匿性导管故障。导管阻塞值得进一步研究,可能需要常规评估导管通畅性以防止治疗效果不佳。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验